Abstract
Background: Conduction velocity (CV) is a measure of the health of myocardial tissue. It can be measured by taking differences in activation times from intracardiac electrodes. Several factors introduce error into the measurement, amongst which, ignoring the three dimensional aspect is a major detriment. The purpose of this paper was to determine if, nonetheless, there was a specific region where CV could be accurately measured. Methods: Computer simulations of three dimensional ventricles with a realistic His-Purkinje system were performed. Ventricles also included a dense scar or diffuse fibrosis. Results: A finer spatial sampling produced better agreement with true CV. Using a error limit of 10 cm/s as a threshold, measurements taken within a region less than 2 cm from the pacing site proved to be accurate. Error increased abruptly beyond this distance. The Purkinje system and tissue fibre orientation played equally major roles in leading to a surface CV which was not reflective of the CV propagation through the tissue. Conclusions: Surface CV measurements close to the pacing site taken with an electrode spacing of at most 1 mm, give reasonable estimates of tissue CV.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
EJV and JB were supported by the French Government as part of the ?Investments of the 267 Future? program managed by the National Research Agency (ANR), Grant reference ANR-10-268 IAHU-04. JB was also supported by the European Union?s Horizon 2020 research and innovation 269 program under the ERA-NET co-fund action No. 680969 with ANR [ERA-CVD SICVALVES 270 grant ANR-19-ECVD-0006]. CR acknowledges support from a UKRI Future Leaders Fellowship 271 (MR/W004720/1). This work was performed using HPC resources from GENCI?IDRIS (Grant 272 A0140310517).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
These are computer simulations with no clinical data.
